NYSE | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.11% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 5.02% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.98% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.95% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 4.90% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.75% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.67% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.57% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.56% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 4.16% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.61% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.58% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.35% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.25% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.21% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.10% |